(1)
Caporali, R.; Ravasio, R.; Raimondo, P.; Salaffi, F. Erratum In: Cost Per Responder for Upadacitinib Vs Abatacept in Patients With Moderate-to-Severe Rheumatoid Arthritis in Italy. Grhta 2022, 9, 30.